ProtekDuo as a bridge to lung transplant and heart-lung transplant

Neeraj Sinha, Ahmad Goodarzi, Radhika Akku, Galit Balayla

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Recent advances in technology have led to significantly greater use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation with better outcomes. The novel ProtekDuo veno-venous ECMO (CardiacAssist, Inc.) has gained significance as it facilitates effective decompression of the right heart in patients with acute decompensation, while also providing consistent and effective gas exchange by eliminating recirculation. Here, we report two cases of effectively using ProtekDuo veno-venous ECMO: one case as a bridge to lung transplantation and another case as a bridge to heart-lung transplantation.

Original languageEnglish (US)
Article numbere14273
Pages (from-to)e14273
JournalClinical Transplantation
Issue number5
StatePublished - May 2021


  • ECMO
  • ProtekDuo
  • heart-lung transplant
  • lung transplant
  • Lung Transplantation
  • Extracorporeal Membrane Oxygenation
  • Heart-Lung Transplantation
  • Humans
  • Treatment Outcome

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'ProtekDuo as a bridge to lung transplant and heart-lung transplant'. Together they form a unique fingerprint.

Cite this